官方服务：
资源简介：
Sox2 signature in SHH medulloblastomas
应用场景：
创建时间：
2015-12-31
相关数据集
Additional file 5 of Integrated analysis of circulating and tissue proteomes reveals that fibronectin 1 is a potential biomarker in papillary thyroid cancer
Additional file 5: Supplementary Table S5. Differentially expressed proteins between tumor tissues and paired non-cancerous adjacent tissues of papillary thyroid cancer patients.
Figshare2024-02-14 更新60
Tumor1216 slide 4
This is the single-cell western blot image data showing primary Tumor1216 cells immunoprobed by:HER2 antibody (488 nm laser channel)GAPDH antibody (532 nm laser channel)Actinin antibody (635 nm laser
Figshare2018-03-04 更新30
DataSheet_1_A novel risk score model based on gamma-aminobutyric acid signature predicts the survival prognosis of patients with breast cancer.zip
BackgroundGamma-aminobutyric acid (GABA) participates in the migration, differentiation, and proliferation of tumor cells. However, the GABA-related risk signature has never been investigated. Hence,
NIAID Data Ecosystem10
Postoperative Serum Levels of sCD26 for Surveillance in Colorectal Cancer Patients
One of the main aims of the follow-up after curative resection of colorectal cancer is the early detection and treatment of tumor recurrence. We previously demonstrated decreased preoperative soluble
Figshare2016-01-15 更新50
BRCAness, SLFN11 and RB1 loss predict response to topoisomerase I inhibitors in triple negative breast cancers. BRCAness, SLFN11 and RB1 loss predict response to topoisomerase I inhibitors in triple negative breast cancers
Expression data from patient-derived xenografts of human triple-negative breast cancers Overall design: We used GeneChip Human 1.1 ST arrays to identify the genes differentially expressed in PDX with
NIAID Data Ecosystem20
